Midbrain Organoid Platform & Services

About OrganoTherapeutics

OrganoTherapeutics is a preclinical-stage biotech leveraging human iPSC-derived midbrain organoids to model Parkinson's Disease and other brain disorders. Its core platform generates patient-specific 3D brain models, including assembloids and microglia-enriched systems, which are used for drug testing and research services. The company integrates high-content imaging and RNA-seq data into a proprietary PD Knowledge Graph to enhance target discovery and validation, positioning itself at the intersection of advanced organoid technology and computational biology.

Therapeutic Areas